Dynavax Technologies reported $120K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adma Biologics ADMA:US $ 0.01M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Amgen AMGN:US $ 31989M 112M
AstraZeneca AZN:LN 387M 59M
Astrazeneca AZN:US $ 387M 59M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Chimerix CMRX:US $ 0.09M 0M
Dynavax Technologies DVAX:US $ 0.12M 0.01M
Glaxosmithkline GSK:US $ 1347M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Idera Pharmaceuticals IDRA:US $ 0.05M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M